Pathophysiology of glaucoma

Glaucoma: Basic and Clinical Perspectives

Volumn , Issue , 2013, Pages 33-57

  Dimitriou, Chrysostomos D ^a   Broadway, David C ^a  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84957101452     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.2217/EBO.12.421     Document Type: Chapter

References (57)

1. Sultan MB, Mansberger SL, Lee PP. Understanding the importance of IOP variables in glaucoma: a systematic review. Surv. Ophthalmol. 54(6), 643-662 (2009).
2. Tan JC, Peters DM, Kaufman PL. Recent developments in understanding the pathophysiology of elevated intraocular pressure. Curr. Opin Ophthalmol. 17(2), 168-174 (2006).
3. Friedman DS, Foster PJ, Aung T, He M. Angle closure and angle-closure glaucoma: what we are doing now and what we will be doing in the future. Clin. Experiment. Ophthalmol. 40(4), 381-387 (2012).
4. Nongpiur ME, Ku JY, Aung T. Angle closure glaucoma: a mechanistic review. Curr. Opin Ophthalmol. 22(2), 96-101 (2011).
5. American Academy of Ophthalmology. Glaucoma; Section 10. Basic and Clinical Science Course American Academy of Ophthalmology (2012-2013).
6. Kanski, JJ, Bowling B. Clinical Ophthalmology: a Systematic Approach. (7th Edition) Elsevier Saunders Ltd. (2011).
7. Ichhpujani P, Jindal A, Jay Katz L. Silicone oil induced glaucoma: a review. Graefes Arch Clin. Experiment. Ophthalmol. 247(12), 1585-1593 (2009).
8. Quigley HA, Friedman DS, Congdon NG. Possible mechanisms of primary angle-closure and malignant glaucoma. J. Glaucoma 12(2), 167-180 (2003).
9. Sihota R. Classification of primary angle closure disease. Curr. Opin Ophthalmol. 22(2), 87-95 (2011).
10. Ng WT, Morgan W. Mechanisms and treatment of primary angle closure: a review. Clin. Experiment. Ophthalmol. 40(4), e218-228 (2012).
11. Tarongoy P, Ho CL, Walton DS. Angle-closure glaucoma: the role of the lens in pathogenesis, prevention & treatment. Surv. Ophthalmol. 54(2), 211-225 (2009).
12. Papaconstantinou D, Georgalas I, Kourtis N et al. Lens-induced glaucoma in the elderly. Clin. Interv. Aging 4, 331-336 (2009).
13. Schacknow P, Samples J. The Glaucoma Book. Springer Science & Business Media, NY, USA (2010).
14. Shields MB. Shields' Textbook of Glaucoma (5th Edition). Lippincott Williams & Wilkins, PA, USA (2005).
15. Shazly TA, Latina MA. Neovascular glaucoma: etiology, diagnosis and prognosis. Semin. Ophthalmol. 24(2), 113-121 (2009).
16. Yanoff M, Duker JS. Ophthalmology (3rd Edition). Mosby Elsevier Inc., London, UK (2009).
17. Tombran-Tink J, Barnstable CJ, Shields MB. Ophthalmology Research: Mechanisms of the Glaucomas. Disease Processes and Therapeutic Modalities. Humana Press, NJ, USA (2008).
18. Morris RW, Dunbar MT. Atypical presentation and review of the ICE syndrome. Optometry 75(1), 13-25 (2004).
19. Dada T, Gadia R, Sharma A, Ichhpujani P et al. Ultrasound biomicroscopy in glaucoma. Surv. Ophthalmol. 56(5), 433-450 (2011).
20. Kuchtey RW, Lowder CY, Smith SD. Glaucoma in patients with ocular inflammatory disease. Ophthalmol. Clin. North Am. 18(3), 421-430 (2005).
21. Sung VC, Barton K. Management of inflammatory glaucomas. Curr. Opin Ophthalmol. 15(2), 136-140 (2004).
22. Razeghinejad MR, Pro MJ, Katz LJ. Non-steroidal drug-induced glaucoma. Eye (Lond.) 25(8), 971-980 (2011).
23. Lai JS, Gangwani RA. Medication-induced acute angle closure attack. Hong Kong Med J. 18(2), 139-145 (2012).
24. Quigley HA. Glaucoma. Lancet 377(9774), 1367-1377 (2011).
25. Lee RK. The molecular pathophysiology of pseudoexfoliation glaucoma. Curr. Opin Ophthalmol. 19(2), 95-101 (2008).
26. Niyadurupola N, Broadway DC. Pigment dispersion syndrome and pigmentary glaucoma-a major review. Clin. Experiment. Ophthalmol. 36, 868-882 (2008).
27. Shazly TA, Aljajeh M, Latina MA. Posner-Schlossman glaucomatocyclitic crisis. Semin. Ophthalmol. 26(4-5), 282-284 (2011).
28. Takusagawa HL, Liu Y, Wiggs JL. Infectious theories of Posner-Schlossman syndrome. Int. Ophthalmol. Clin. 51(4), 105-115 (2011).
29. Montenegro MH, Simmons RJ. Ghost cell glaucoma. Int. Ophthalmol. Clin. 35(1), 111-115 (1995).
30. Tumbocon JA, Latina MA. Angle recession glaucoma. Int. Ophthalmol. Clin. 42(3), 69-78 (2002).
31. Matsuo T, Muraoka N, Shiraga F, Matsuo N. Schwartz-Matsuo syndrome in retinal detachment with tears of the non-pigmented epithelium of the ciliary body. Acta Ophthalmol. Scand. 76(4), 481-485 (1998).
32. Razeghinejad MR, Katz LJ. Steroid-induced iatrogenic glaucoma. Ophthalmic Res. 47(2), 66-80 (2012).
33. Razeghinejad MR, Myers JS, Katz LJ. Iatrogenic glaucoma secondary to medications. Am J. Med. 124(1), 20-25 (2011).
34. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet 363(9422), 1711-1720 (2004).
35. Chang EE, Goldberg JL. Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement. Ophthalmology 119(5), 979-986 (2012).
36. Tektas OY, Lütjen-Drecoll E. Structural changes of the trabecular meshwork in different kinds of glaucoma. Exp. Eye Res. 88(4), 769-775 (2009).
37. Karmel M. Glaucoma research moves ahead on two fronts: the brain and the "drain". EyeNet (Am. Acad. Ophthalmol.) 36-41 (2011).
38. Morrison JC, Cepurna Ying Guo WO, Johnson EC. Pathophysiology of human glaucomatous optic nerve damage: insights from rodent models of glaucoma. Exp. Eye Res. 93(2), 156-164 (2011).
39. Yorio T, Krishnamoorthy R, Prasanna G. Endothelin: is it a contributor to glaucoma pathophysiology? J. Glaucoma 11(3), 259-270 (2002).
40. Jonas JB. Role of cerebrospinal fluid pressure in the pathogenesis of glaucoma. Acta Ophthalmol. 89(6), 505-514 (2011).
41. Malik R, Swanson WH, Garway-Heath DF. Structurefunction relationship in glaucoma: past thinking and current concepts. Clin. Experiment. Ophthalmol. 40(4), 369-380 (2012).
42. Sit AJ, Liu JH. Pathophysiology of glaucoma and continuous measurements of intraocular pressure. Mol. Cell Biomech. 6(1), 57-69 (2009).
43. Yanagi M, Kawasaki R, Wang JJ et al. Vascular risk factors in glaucoma: a review. Clin. Experiment. Ophthalmol. 39(3), 252-258 (2011).
44. Nicolela MT. Clinical clues of vascular dysregulation and its association with glaucoma. Can. J. Ophthalmol. 43(3), 337-341 (2008).
45. Grieshaber MC, Mozaffarieh M, Flammer J. What is the link between vascular dysregulation and glaucoma? Surv. Ophthalmol. 2(Suppl. 2), S144-S154 (2007).
46. Chung HS, Harris A, Evans DW et al. Vascular aspects in the pathophysiology of glaucomatous optic neuropathy. Surv. Ophthalmol. 43(Suppl. 1), S43-S50 (1999).
47. Broadway DC, Drance SM. Glaucoma and vasospasm. Br. J. Ophthalmol. 82, 862-870 (1998).
48. Moreno MC, Sande P, Marcos HA et al. Effect of glaucoma on the retinal glutamate/ glutamine cycle activity. FASEB J. 19, 1161-1162 (2005).
49. Agarwal R, Gupta SK, Agarwal P et al. Current concepts in the pathophysiology of glaucoma. Indian J. Ophthalmol. 57(4), 257-266 (2009).
50. Gugleta K, Fuchsjäger-Mayrl G, Orgül S. Is neurovascular coupling of relevance in glaucoma? Surv. Ophthalmol. 52(Suppl. 2), S139-S143 (2007).
51. Yücel YH, Gupta N. Paying attention to the cerebrovascular system in glaucoma. Can. J. Ophthalmol. 43(3), 342-346 (2008).
52. Izzotti A, Bagnis A, Saccà SC. The role of oxidative stress in glaucoma. Mutat Res. 612(2), 105-114 (2006).
53. Flammer J, Mozaffarieh M. What is the present pathogenetic concept of glaucomatous optic neuropathy? Surv. Ophthalmol. 52(6), 162-173 (2007).
54. Shazly TA, Aljajeh M, Latina MA. Autoimmune basis of glaucoma. Semin. Ophthalmol. 26(4-5), 278-281 (2011).
55. Tezel G. The role of glia, mitochondria, and the immune system in glaucoma. IOVS 50(3), 1001-1012 (2009).
56. Almasieh M, Wilson AM, Morquette B et al. The molecular basis of retinal ganglion cell death in glaucoma. Prog. Retin. Eye Res. 31(2), 152-181 (2012).
57. Crawford Downs J, Roberts MD, Sigal IA. Glaucomatous cupping of the lamina cribrosa: a review of the evidence for active progressive remodeling as a mechanism. Exp. Eye Res. 93(2), 133-140 (2011).